Cargando…
Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19()
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedad Española de Nefrología. Published by Elsevier España, S.L.U.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062028/ https://www.ncbi.nlm.nih.gov/pubmed/36165388 http://dx.doi.org/10.1016/j.nefroe.2021.04.001 |
| _version_ | 1783681684269432832 |
|---|---|
| author | Sánchez Cadena, Abraham David Negreira Caamaño, Martín Pérez Serrano, Raúl Porras Leal, María Lourdes |
| author_facet | Sánchez Cadena, Abraham David Negreira Caamaño, Martín Pérez Serrano, Raúl Porras Leal, María Lourdes |
| author_sort | Sánchez Cadena, Abraham David |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8062028 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80620282021-04-23 Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19() Sánchez Cadena, Abraham David Negreira Caamaño, Martín Pérez Serrano, Raúl Porras Leal, María Lourdes Nefrologia (Engl Ed) Letter to the Editor Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. 2021 2021-04-22 /pmc/articles/PMC8062028/ /pubmed/36165388 http://dx.doi.org/10.1016/j.nefroe.2021.04.001 Text en © 2020 Sociedad Española de Nefrología. Published by Elsevier España, S.L.U. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Sánchez Cadena, Abraham David Negreira Caamaño, Martín Pérez Serrano, Raúl Porras Leal, María Lourdes Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19() |
| title | Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19() |
| title_full | Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19() |
| title_fullStr | Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19() |
| title_full_unstemmed | Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19() |
| title_short | Intravenous immunoglobulins: A therapeutic alternative to consider in kidney transplant patients with COVID-19() |
| title_sort | intravenous immunoglobulins: a therapeutic alternative to consider in kidney transplant patients with covid-19() |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062028/ https://www.ncbi.nlm.nih.gov/pubmed/36165388 http://dx.doi.org/10.1016/j.nefroe.2021.04.001 |
| work_keys_str_mv | AT sanchezcadenaabrahamdavid intravenousimmunoglobulinsatherapeuticalternativetoconsiderinkidneytransplantpatientswithcovid19 AT negreiracaamanomartin intravenousimmunoglobulinsatherapeuticalternativetoconsiderinkidneytransplantpatientswithcovid19 AT perezserranoraul intravenousimmunoglobulinsatherapeuticalternativetoconsiderinkidneytransplantpatientswithcovid19 AT porraslealmarialourdes intravenousimmunoglobulinsatherapeuticalternativetoconsiderinkidneytransplantpatientswithcovid19 |